Report updated May 19, 2026
Davis's Drug Guide - Nurses
For nursing students, practicing nurses, physicians, and pharmacists requiring reliable, updated medication reference data.
Davis's Drug Guide - Nurses is an established medical app that is available. With a 4.8/5 rating from 11.1K reviews, it shows polarized user reception. Users particularly appreciate succinct medication monographs provide reliable clinical reference for nursing students and practitioners, though subscription and login errors prevent access to paid content across devices remains a common concern.
What is Davis's Drug Guide - Nurses?
Davis's Drug Guide is a medical reference app for nurses and physicians providing drug monographs, IV calculators, and pill identification tools on iOS and Android.
Users hire the app to ensure medication safety and clinical accuracy during high-stakes nursing shifts, where reliable, updated dosing data is a professional requirement.
Current Momentum
v1.57 · 5d ago
Maintenance- Added pediatric and adult immunization appendix.
- Upgraded payment technology for purchase reliability.
Active Nemesis
Drugs.com Medication Guide
By Drugs.com
Other Rivals
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
Recent User Mood
What makes this app unique?
What Does It Look Like?
What Are The Key Features?
1,700+ entries covering 5,000+ trade and generic medications with safety alerts and REMS data
Integrated tools for calculating drips and dosing directly within the app
Cross-platform access to the database via web browser after app purchase
How much does it cost?
- 14-day free trial
- $39.99 for a one-year subscription
Subscription model anchored at $39.99/year, utilizing a free trial period to convert students and professionals into annual recurring revenue.
Who Built It?
Unbound Medicine
Equipping healthcare professionals with evidence-based clinical decision support and integrated reference tools at the point of care.
Portfolio
13
Apps
What other apps does Unbound Medicine make?
DSM-5-TR® Diagnosis Handbook
5-Minute Emergency Medicine
Johns Hopkins Antibiotic Guide
Nursing Central
Oxford Handbook Clinical Med
Oxford Emergency Medicine
Explore the full Unbound Medicine report
Portfolio breakdown, audience, momentum, and every app published by Unbound Medicine.
What do users think recently?
High confidence · Latest 70 of 102 total reviews analyzed · Based on 102 reviews. Signal may be noisy.
How did the latest release land?
What is the recent mood?
Recent user voice shows a mixed sentiment. Users appreciate succinct medication monographs provide reliable clinical reference for nursing students and practitioners and integrated dosage and infusion calculators assist with critical medication safety checks, but report subscription and login errors prevent access to paid content across devices and transition to a mandatory subscription model alienates users who previously accessed content via textbooks.
What Users Love
What Frustrates Users
What Users Want
How have ratings & review volume moved?
Rating, review sentiment, and total reviews over time, with release markers showing the post-launch impact.
Vertical markers = app releases. Hover any release for the post-release impact delta.
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
What is the competitive landscape for Davis's Drug Guide - Nurses?
Where is it available?
Localized markets (1)
How's The Medical Market?
How does it evolve in the Medical market?
Davis's Drug Guide holds the #10 Grossing position in the US Medical category, but the gap between its high utility and the #30-34 rankings in international markets suggests the $39.99/year price point is a barrier to global adoption.
Rank progression
35 active rankings tracked — 30-day window
Which niche is Davis's Drug Guide - Nurses in?
to safely administer and research medications
Explore the full Pharmacology Guides niche
Every app in this space — 6 tracked, the niche's live rankings, and Marlvel's editorial take on the job-to-be-done.
The rivals identified
Nemeses(1)
With over 36,000 reviews and a massive, established user base, this is the primary market leader for general medication information.
Differentiators
- Provides a comprehensive, free-to-access pill identification tool that integrates directly with medication guides
- Maintains a massive, centralized database that serves as a primary reference for both patients and clinicians
- Offers a broader, consumer-facing utility that captures high-volume search traffic compared to specialized nursing guides
Head to head
The target app should double down on its specialized nursing-specific clinical utility to differentiate from the broader, general-purpose reach of Drugs.com.
Contenders(2)
The gold standard for clinical decision support, serving as a high-barrier-to-entry alternative for medical professionals.
Differentiators
- Focuses on evidence-based clinical decision support rather than just medication reference and dosing calculators
- Requires institutional or professional subscriptions, creating a high-value, gated experience for serious medical practitioners
High-velocity release cadence with 14 updates in six months signals a massive, aggressive push for clinical dominance.
Differentiators
- Integrates a massive, multi-specialty clinical news feed that keeps users engaged beyond simple drug lookups
- Provides a comprehensive suite of CME-accredited courses directly within the app to drive professional retention
Same space(3)
A highly respected, authoritative medical reference that serves as a trusted, static knowledge base.
Differentiators
- Provides authoritative, peer-reviewed medical content that is widely recognized as a standard clinical reference
- Maintains a clean, text-heavy interface that prioritizes clinical accuracy and depth over interactive features
Focuses specifically on clinical calculators and decision tools rather than comprehensive drug monographs.
Differentiators
- Specializes in high-utility clinical calculators that solve specific, time-sensitive diagnostic problems for clinicians
- Optimized for rapid, point-of-care decision support rather than long-form medication reference and safety data
Offers a modular library approach that allows users to build a custom collection of medical references.
Differentiators
- Utilizes a modular, 'a la carte' content delivery model that lets users purchase specific medical texts
- Provides a highly customizable interface for managing multiple medical references within a single unified library
New entrants(1)
A focused, single-purpose tool that addresses a specific, high-frequency user pain point with recent updates.
Differentiators
- Simplifies the complex drug identification process into a streamlined, visual-first user experience for rapid results
- Targets the specific 'what is this pill?' user intent that often leads to broader medication guide discovery
Compare Davis's Drug Guide - Nurses against every rival
All rivals in one side-by-side table — identity, store metrics, ratings & sentiment, and strategic intel — plus a head-to-head page for each.
The outtake for Davis's Drug Guide - Nurses
Strengths to defend, gaps to attack
Core Strengths
- Integrated IV calculators function as a daily-use clinical retention loop
- Exclusive DrugGuide.com web access creates a multi-surface professional workflow
Critical Frictions
- 0.06★ rating gap between iOS and Android indicates authentication instability
- $39.99/year subscription model lacks a one-time purchase option for legacy users
Growth Levers
- Dark mode implementation would address the #1 UI-specific request for night-shift staff
- License portability across platforms would reduce the high-frequency login complaint
Market Threats
- Drugs.com's free pill identification tool captures top-of-funnel users
- Mandatory subscription shifts alienate the core nursing student segment
What are the next best moves?
Ship account-based license portability because login errors are the top-cited churn driver → increase retention
User reviews consistently cite inability to restore purchases or access content across devices.
Trade-off: Deprioritize the planned UI refresh for the monograph search interface.
Audit authentication logic because subscription-access failures are suppressing sentiment → improve rating baseline
Sentiment analysis shows high-frequency complaints regarding subscription recognition post-update.
Trade-off: Same-quarter capacity available — no major lever displaced.
A counter-intuitive read
The #10 Grossing rank is a vulnerability: the app's reliance on a $39.99/year subscription model creates a price ceiling that allows free, ad-supported competitors to capture the high-volume student market.
Feature Gaps vs Competitors
- Real-time clinical news feed (available in Medscape but absent here)
- CME-accredited course integration (available in Medscape but absent here)
Key Takeaways
Davis's Drug Guide maintains clinical authority through its integrated calculators, but the recurring authentication failures threaten its subscription revenue, so the PM must prioritize account-based license portability to stop the churn of professional users.
Where Is It Heading?
Declining
The clinical reference market is consolidating around high-velocity, multi-surface tools, leaving Davis's Drug Guide exposed due to its rigid subscription-only model and authentication friction. If the team does not solve the cross-platform login issue, the current #10 Grossing rank will likely erode as users migrate to more stable, free-to-access alternatives.
Persistent authentication failures post-update erode professional trust, which directly suppresses the app's long-term subscription renewal rate.
The shift to a mandatory subscription model alienates legacy textbook users, accelerating churn among the core nursing student segment.